Starboard Value has 1 million-share stake in Bristol-Myers Squibb, has met with management
February 20, 2019 at 11:33 AM EST
Bristol-Myers Squibb confirms Starboard's stake in the company and says the $74 billion deal to acquire cancer drugmaker Celgene is "on track" to close during the third quarter.
